| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b93b3d1b9fed5e91732832116309bd2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 |
| filingDate |
2006-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85b084286a9881ef13644d09284d8c99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8d0dae28436534e9cc260477c545321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a95cbaa344232073c62b7ee93bbe4a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c00eaaefe070c785e4ea09e75016fd79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0eda9e82aaddd3b356518a0d593ac01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e52e9b1985d225354d692b3a667de331
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b66c61c143d4a6b70d55675b160db153
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9400863e7d742ec6585bf8aa1d36b5cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9ac72875613b4a355dd3394ef5a9865 |
| publicationDate |
2008-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1960356-A2 |
| titleOfInvention |
Multivalent indole compounds and use thereof as phospholipase-a2 inhibitors |
| abstract |
Indole and indole-related compounds, compositions and methods are disclosed. The compounds of the invention are useful as phospholipase inhibitors. The compounds and compositions of the invention are useful for treatment of phospholipase- related conditions, such as insulin-related, weight-related and/or cholesterol-related conditions in an animal subject. The compounds of the invention consist of linked indole derivatives having at ' least two bicyclic rings of formula FIG. 6C in which R1R7 are defined as in claim 1 and in which the fused five membered ring contains a nitrogen atom and the fused six membered ring optionally contains one or two nitrogen atoms. The two or more bicyclic rings of Figure 6c are joined by a multifunctional bridge moiety substituted by two or more linking groups L which are joined to the bicyclic ring. |
| priorityDate |
2005-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |